Unique ID issued by UMIN | UMIN000008283 |
---|---|
Receipt number | R000009633 |
Scientific Title | Impact of Clinical Parameters Including Endothelial Dysfunction on Procedure-related and Contrast-induced Renal Damage (PCRD) in Patients with Underwent Coronary Angiography |
Date of disclosure of the study information | 2012/07/01 |
Last modified on | 2017/09/20 10:42:30 |
Impact of Clinical Parameters Including Endothelial Dysfunction on Procedure-related and Contrast-induced Renal Damage (PCRD) in Patients with Underwent Coronary Angiography
Impact of Clinical Parameters Including Endothelial Dysfunction on Procedure-related and Contrast-induced Renal Damage (PCRD) in Patients with Underwent Coronary Angiography
Impact of Clinical Parameters Including Endothelial Dysfunction on Procedure-related and Contrast-induced Renal Damage (PCRD) in Patients with Underwent Coronary Angiography
Impact of Clinical Parameters Including Endothelial Dysfunction on Procedure-related and Contrast-induced Renal Damage (PCRD) in Patients with Underwent Coronary Angiography
Japan |
stable patients with angina-like chest pain who were referred and scheduled for cardiac catheterization
Cardiology |
Others
NO
To examine clinical parameters including endothelial dysfunction would have an effect on the occurrence of PCRD
Safety
Confirmatory
Pragmatic
Not applicable
We defined the occurrence of PCRD as any increase in serum creatinine measured before and after the procedures
Observational
20 | years-old | <= |
Not applicable |
Male and Female
Stable patients with angina-like chest pain who were referred and scheduled for cardiac catheterization including coronary angiography and coronary intervention
Patients with acute coronary syndrome who requires emergent coronary procedure, established CKD [estimated glomerular filtration rate (eGFR) <60ml/min/1.75m2], other contrast exposure within one week or less from the index procedure, symptomatic heart failure [left ventricular ejection fraction < 50% and/or plasma B-type natriuretic peptide (BNP) level >200pg/ml], collagen disease, neuromuscular disease, and malignant disease
300
1st name | |
Middle name | |
Last name | Seigo Sugiyama |
Graduate School of Medical Sciences, Kumamoto University
Department of Cardiovascular Medicine
1-1-1 Honjo, Kumamoto City 860-8556, Japan
81-96-373-5175
ssugiyam@kumamoto-u.ac.jp
1st name | |
Middle name | |
Last name | Hitoshi Sumida |
Graduate School of Medical Sciences, Kumamoto University
Department of Cardiovascular Medicine
1-1-1 Honjo, Kumamoto City 860-8556, Japan
81-96-373-5175
ssugiyam@kumamoto-u.ac.jp
Graduate School of Medical Sciences, Kumamoto University
Scientific Research (No. C19590869 for S. Sugiyama) from the Ministry of Education, Science, and Culture in Japan
Japanese Governmental office
Japan
NO
熊本大学附属病院
2012 | Year | 07 | Month | 01 | Day |
Published
Completed
2006 | Year | 08 | Month | 01 | Day |
2006 | Year | 08 | Month | 01 | Day |
2011 | Year | 04 | Month | 01 | Day |
2011 | Year | 04 | Month | 01 | Day |
2011 | Year | 04 | Month | 01 | Day |
2012 | Year | 07 | Month | 01 | Day |
Patients who developed PCRD exhibited significant impairment of peripheral endothelial function. The underlying endothelial dysfunction might play an important role in pathogenesis of PCRD.
2012 | Year | 06 | Month | 27 | Day |
2017 | Year | 09 | Month | 20 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000009633
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |